Journal
MOLECULAR PHARMACEUTICS
Volume 7, Issue 4, Pages 944-952Publisher
AMER CHEMICAL SOC
DOI: 10.1021/mp100076x
Keywords
Biomarker detection; human alpha 1-antitrypsin precursor; polyHEMA; immobilized trypsin; spacers; real time detection; ELISA
Funding
- NEMO consortium
Ask authors/readers for more resources
Early diagnosis of gastric carcinoma is crucial for maximizing medical treatment efficacy. For the purpose of real time diagnosis (virtual biopsy) of stomach malignancy we developed a polyHEMA platform capable of capturing human alpha 1-antitrypsin precursor (A1AT); a model proteinaceous luminal biomarker. Its specific attachment to the polymeric platform was accomplished by immobilized trypsin, which was linked to the surface of the polyHEMA film by a series of PEG-based spacers. Recognition was enabled by adapting an ELISA-like methodology, using rabbit anti-A1AT and HRP-conjugated anti-rabbit IgG as a secondary antibody. Since this A1AT-sensing platform was designed to be detected by endoscopic means such as a video capsule, its physical stability was tested after casting on top of a polycarbonate surface. It was found that, in contrast to classical ELISA analysis performed on polystyrene plates, A1AT detection was possible only when spacer arms were used to immobilize the capturing moiety, trypsin, with a 7-fold increase in the optical signal and a saturation kinetics dependency upon the concentration of the A1AT biomarker.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available